skip to primary navigationskip to content

Nobel-winning drug 'tackles malaria'.

last modified Oct 28, 2015 10:11 AM
Early data coming out of trials of ivermectin in Burkina Faso suggest it leads to 16% fewer cases of childhood malaria.

Scientists at the American Society of Tropical Medicine and Hygiene's conference, said the drug was toxic to blood-drinking mosquitoes.

They said their findings were pretty exciting, but still at an early stage.

Ivermectin is already used to kill parasitic worms, which affect a third of the world's population and cause illnesses including river blindness and lymphatic filariasis.

Its discovery won this year's Nobel Prize for Physiology or Medicine.

More can be read on the BBC health website http://www.bbc.co.uk/news/health-34649016

Upcoming events

Drug Discovery Seminar

May 10, 2017

Pavilion Room, Hughes Hall, Cambridge, CB1 2EW

Cambridge Immunology PhD and Postdoc Day 2017

Jun 08, 2017

Cancer Research UK, Cambridge Institute

Emerging Viruses of Zoonotic and Veterinary Importance

Jul 24, 2017

Churchill College, Cambridge

Exploring Human Host-Microbiome Interactions in Health and Disease

Sep 13, 2017

Wellcome Conference Centre, Hinxton

Upcoming events

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more